I agree that the chart shows a steep slope, but I would not compare MJ stock with CBIS. The ski slope that MJ shows may be the result of lack of a business focus, which seems to change with the seasons....I expect more snow on that slope.
On the other hand, the focus of CBIS has been consistently focused on development of medicine that can affect millions. The recent news about GW Pharm, dispensary acquisitions to fund current operations and generate revenue, leads more to investor confidence that a "product" may be approved that will light this candle.
The rest of this week will be an indicator, imo, of whether we will flounder more, or head north. I do think the pressure is building here at CBIS judging by the increase in volume.